CSII News and Press, Cardiovascular Systems Inc. From 11/09/21

Image source: The Motley Fool. Cardiovascular Systems, inc (NASDAQ: CSII) Q1 2022 Earnings Call Nov 9, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: Cardiovascular Systems, inc (CSII) Q1 2022 Earnings Call Transcr...

Cardiovascular Systems (NASDAQ:CSII): Q1 GAAP EPS of -$0.22 misses by $0.12. Revenue of $58.4M (-3.5% Y/Y) misses by $5.32M. Press Release As of September 30, 2021, CSI had cash and marketable securities totaling $187.6M and no long-term borrowings. For further details see: Cardiovascul...

Conference Call Scheduled for Today, November 9, 2021, at 8:00 AM CT (9:00 AM ET) Revenues of $58.4 million decreased 3.6% compared to first quarter last year Procedure volumes adversely impacted by hospital constraints and staffing shortages caused by the COVID-19 D...

Because the COVID-19 pandemic is far from over, the healthcare industry is expected to remain in the limelight of investor interest. Moreover, with technological advancements and government spending, the medical equipment/supplies market is expected to grow significantly in the coming months....

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the start of enrollment in a first in-human tr...

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host inve...

Live Webcast at 8:00 a.m. CT (9:00 a.m. ET) Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) will host a live webcast of its fiscal 2022 first-quarter conference call on Tuesday, November 9, 2021, at 8:00 a.m. CT (9:00 a.m. ET). CSI management will discuss r...

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient has been successfully treated with its ...

Given rising uncertainties in the stock market, it could be wise to bet on beaten-down stocks that possess solid growth attributes. And we believe Cardiovascular Systems (CSII) and Itron (ITRI) meet those qualifications. They both look undervalued at their current price levels and have the po...

Introduction of Orbital Atherectomy in Canada Expands Treatment Options for Patients with Complex Coronary Artery Disease Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional ...